Enzo Clinical Labs Kara Cannon
2019
In 2019, Enzo Clinical Labs Kara Cannon earned a total compensation of $378.5K as Chief Commercial Officer at Enzo Biochem.
Compensation breakdown
| Non-Equity Incentive Plan | $60,000 |
|---|---|
| Option Awards | $56,316 |
| Salary | $220,000 |
| Stock Awards | $29,400 |
| Other | $12,802 |
| Total | $378,518 |
Cannon received $220K in salary, accounting for 58% of the total pay in 2019.
Cannon also received $60K in non-equity incentive plan, $56.3K in option awards, $29.4K in stock awards and $12.8K in other compensation.
Rankings
In 2019, Enzo Clinical Labs Kara Cannon's compensation ranked 12,484th out of 13,971 executives tracked by ExecPay. In other words, Cannon earned more than 10.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 12,484 out of 13,971 | 11th |
Division Services | 2,156 out of 2,389 | 10th |
Major group Health Services | 219 out of 237 | 8th |
Industry group Medical And Dental Laboratories | 67 out of 75 | 11th |
Industry Medical Laboratories | 67 out of 75 | 11th |
Source: SEC filing on November 27, 2020.
Cannon's colleagues
We found three more compensation records of executives who worked with Enzo Clinical Labs Kara Cannon at Enzo Biochem in 2019.